| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |